𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tamoxifen after breast cancer reduces the risk of cancer in the second breast in BRCA1 and BRCA2 carriers

✍ Scribed by Ruth M. O'Regan


Book ID
117836698
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
227 KB
Volume
3
Category
Article
ISSN
1361-259X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Tamoxifen and contralateral breast cance
✍ Jacek Gronwald; Nadine Tung; William D. Foulkes; Kenneth Offit; Ruth Gershoni; M πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 77 KB

## Abstract Women with a mutation in __BRCA1__ or __BRCA2__ face a lifetime risk of breast cancer of ∼80%, and following the first diagnosis the10‐year risk of contralateral breast cancer is ∼30%. It has been shown that both tamoxifen and oophorectomy prevent contralateral breast cancer, but it is